The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
Mar 27, 2013
0
0
Led by researchers at the University of Pittsburgh School of Medicine, an international panel of pathologists and clinicians has reclassified a type of thyroid cancer to reflect that it is noninvasive and has a low risk of ...
Apr 14, 2016
0
4
In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free survival in patients with ...
Feb 11, 2015
0
2
Today five influential Australian health-care organisations – representing professionals, the public and policy makers – have released a statement outlining that some medical conditions are being diagnosed too often, ...
Aug 17, 2017
0
1
Researchers at Columbia University's Mailman School of Public Health and Columbia University Medical Center found that patients who did not adhere to their medication schedule for chronic conditions, such as hypertension, ...
Jun 9, 2016
0
2
A diagnosis of thyroid cancer can be devastating to professional singers, because surgical removal of the thyroid commonly causes voice changes. Massachusetts Eye and Ear surgeons developed a neural monitoring system to be ...
Mar 24, 2015
0
3
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumors in patients with nonsmall cell ...
Sep 28, 2020
0
1
A molecule widely believed to fight many forms of cancer actually helps deadly thyroid tumors grow, and cancer therapies now being tested in humans might boost the activity of this newly revealed bad guy, researchers at Mayo ...
Jun 20, 2012
0
0
New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, Ph.D., could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene—a mutation also ...
Jan 9, 2024
0
0
Thyroid cancer is the most common type of endocrine cancer in children. Because it is bilateral—affecting both sides (lobes) of the thyroid—in more than one third of pediatric patients, initial treatment typically involves ...
Mar 1, 2022
0
8
